Last June 22, i-PROGNOSIS was attending the “Value of Treatment for brain disorders” conference organised by the European Brain Council in Brussels. The conference was the occasion to present a two-year study on the economic challenges linked to brain disorders, including Parkinson’s.
The study main conclusions can be grouped in three categories.
The risk reduction was the first and main focus of the “Value of Treatment” study. Risks can be reduced through different ways: primary and proactive prevention, early detection and diagnosis and timely intervention.
Education was also raised as a crucial topic in order to ensure that patient and families associations engage in the discussion. Together, these associations advocate for access to care and medicinal products. Advocacy activities by civil society organisations are very valuable to reduce stigma and discrimination that people diagnosed with a brain disorder experience.
The restructuration of the health service was also underlined as highly needed. Physicians are on the front line to detect diseases and propose appropriate interventions. If physicians are not trained by specialists to identify (rare) brain disorders, they may not be in a position to make the right diagnosis at the right moment.
A case study analyse was conducted on Parkinson’s to identify treatment gaps and unmet needs. The case study can be found at the following link: http://www.braincouncil.eu/activities/projects/the-value-of-treatment/PD
To access the full “Value of Treatment for brain disorders” study, please visit the European Brain Council website: http://www.braincouncil.eu/activities/projects/the-value-of-treatment